Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

TLSG

Founders Michael Sachs

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$3M
Portfolio companies 2
Rounds per year 0.33
Lead investments 1
Exits 1
Key employees 2
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Health Care
  • Medical
  • SaaS
  • Software
  • Food and Beverage
Summary

TLSG appeared to be the VC, which was created in 2015. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Evanston.

This organization was formed by Michael Sachs.

Deals in the range of 1 - 5 millions dollars are the general things for fund. The important activity for fund was in 2015. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2019.

The usual cause for the fund is to invest in rounds with 4 partakers. Despite the TLSG, startups are often financed by The Social Entrepreneurs Fund (TSEF), Serious Change, Rafi Musher. The meaningful sponsors for the fund in investment in the same round are Serious Change, Relativity Healthcare Partners, Kapor Capital. In the next rounds fund is usually obtained by Sandbox Industries, BlueCross BlueShield Venture Partners.

Among the most successful fund investment fields, there are Medical, Health Care. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight BeneStream.

Read more

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Arcis Capital Partners New York, New York, United States
Econolite Anaheim, California, United States
Homsun Capital China, Shanghai
Impulsum Ventures Antioquia, Colombia, Medellín
Kokteyl Istanbul, Istanbul, Turkey
MePay -
RTL Group Investments Australia, New South Wales, Sydney
Shuidishi Fund -
Woori Technology Investment Seoul, Seoul-t'ukpyolsi, South Korea

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

BeneStream

Health Care
Medical
SaaS
Software
$4M08 Jul 2015 New York, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent TLSG?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 3M
Rounds per year 0.33
Peak activity year 2017
Lead investments 1
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

BeneStream

Health Care
Medical
SaaS
Software
$4M08 Jul 2015 New York, United States
Crunchbase icon

Content report

The following text will be sent to our editors: